Back to Search
LISA HILLER, PHARMD
PHARMD
Pharmacist
NPI: 1659673754Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
12944(AZ)
Research & Publications (20)
Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer.
PMID 19533750·Int J Cancer·2009
8-other
Highly polymorphic family of glycosylphosphatidylinositol-anchored surface antigens with evidence of developmental regulation in Toxoplasma gondii.
PMID 17938221·Infect Immun·2008
7-preclinical
tAnGo: a randomised phase III trial of gemcitabine in paclitaxel-containing, epirubicin/cyclophosphamide-based, adjuvant chemotherapy for early breast cancer: a prospective pulmonary, cardiac and hepatic function evaluation.
PMID 18665163·Br J Cancer·2008
3-trial
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
PMID 18599795·Blood·2008
8-other
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of life.
PMID 18797468·Br J Cancer·2008
3-trial
Questioning specialists' attitudes to breast cancer follow-up in primary care.
PMID 17525086·Ann Oncol·2007
8-other
The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation.
PMID 18042300·Health Qual Life Outcomes·2007
4-observational
Epigenetic inactivation implies independent functions for insulin-like growth factor binding protein (IGFBP)-related protein 1 and the related IGFBPL1 in inhibiting breast cancer phenotypes.
PMID 17634530·Clin Cancer Res·2007
8-other
Criterion validity of the BBUSQ-22: a questionnaire assessing bowel and urinary tract symptoms in women.
PMID 17245544·Int Urogynecol J Pelvic Floor Dysfunct·2007
4-observational
A prospective double blind placebo-controlled randomized trial of ultrasound in the physiotherapy treatment of shoulder pain.
PMID 17218327·Rheumatology (Oxford)·2007
4-observational
Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer.
PMID 17079759·N Engl J Med·2006
3-trial
The SDF-1 G > A polymorphism at position 801 plays no role in multiple myeloma but may contribute to an inferior cause-specific survival in chronic lymphocytic leukemia.
PMID 16923552·Leuk Lymphoma·2006
8-other
Glycoalkaloid development during greening of fresh market potatoes (Solanum tuberosum L.).
PMID 16881686·J Agric Food Chem·2006
4-observational
Development and psychometric testing of a symptom index for pelvic organ prolapse.
PMID 16698633·J Obstet Gynaecol·2006
4-observational
Review of second-line chemotherapy for advanced gastric adenocarcinoma.
PMID 15830569·Clin Oncol (R Coll Radiol)·2005
6-review
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo.
PMID 15077186·Oncogene·2004
8-other
Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
PMID 15069539·Oncol Rep·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9100 N SILVERBELL RD
TUCSON, AZ 85743 - Phone
- (520) 579-8826
Quick Facts
- NPI
- 1659673754
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile